vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Purple Innovation, Inc.（PRPL）财务数据对比。点击上方公司名可切换其他公司
Purple Innovation, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$140.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 9.1%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-7.8M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 8.3%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌，由安迪·莱维特创立，每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道，对比美式标准餐食，该品牌每份餐包的碳排放量可降低72%，主打低碳环保的纯植物饮食方案。
PBYI vs PRPL — 直观对比
营收规模更大
PRPL
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出18.6%
9.1%
自由现金流更多
PBYI
多$22.2M
$-7.8M
两年增速更快
PBYI
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $140.7M |
| 净利润 | — | $-3.2M |
| 毛利率 | 69.3% | 41.9% |
| 营业利润率 | 22.7% | -1.6% |
| 净利率 | — | -2.3% |
| 营收同比 | 27.7% | 9.1% |
| 净利润同比 | — | 62.1% |
| 每股收益（稀释后） | $0.26 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIPRPL
| Q4 25 | $75.5M | $140.7M | ||
| Q3 25 | $54.5M | $118.8M | ||
| Q2 25 | $52.4M | $105.1M | ||
| Q1 25 | $46.0M | $104.2M | ||
| Q4 24 | $59.1M | $129.0M | ||
| Q3 24 | $80.5M | $118.6M | ||
| Q2 24 | $47.1M | $120.3M | ||
| Q1 24 | $43.8M | $120.0M |
净利润PBYIPRPL
| Q4 25 | — | $-3.2M | ||
| Q3 25 | $8.8M | $-11.7M | ||
| Q2 25 | $5.9M | $-17.3M | ||
| Q1 25 | $3.0M | $-19.1M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | $20.3M | $-39.2M | ||
| Q2 24 | $-4.5M | $27.0K | ||
| Q1 24 | $-4.8M | $-50.2M |
毛利率PBYIPRPL
| Q4 25 | 69.3% | 41.9% | ||
| Q3 25 | 77.7% | 42.8% | ||
| Q2 25 | 76.5% | 35.9% | ||
| Q1 25 | 77.1% | 39.4% | ||
| Q4 24 | 76.4% | 42.9% | ||
| Q3 24 | 63.9% | 29.7% | ||
| Q2 24 | 77.4% | 40.7% | ||
| Q1 24 | 75.5% | 34.8% |
营业利润率PBYIPRPL
| Q4 25 | 22.7% | -1.6% | ||
| Q3 25 | 17.6% | -10.2% | ||
| Q2 25 | 12.7% | -13.5% | ||
| Q1 25 | 8.7% | -13.9% | ||
| Q4 24 | 22.6% | -6.0% | ||
| Q3 24 | 27.4% | -39.5% | ||
| Q2 24 | -4.6% | -12.1% | ||
| Q1 24 | -5.3% | -19.3% |
净利率PBYIPRPL
| Q4 25 | — | -2.3% | ||
| Q3 25 | 16.2% | -9.9% | ||
| Q2 25 | 11.2% | -16.5% | ||
| Q1 25 | 6.5% | -18.4% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | 25.2% | -33.1% | ||
| Q2 24 | -9.6% | 0.0% | ||
| Q1 24 | -11.0% | -41.8% |
每股收益（稀释后）PBYIPRPL
| Q4 25 | $0.26 | $0.03 | ||
| Q3 25 | $0.17 | $0.11 | ||
| Q2 25 | $0.12 | $0.16 | ||
| Q1 25 | $0.06 | $0.18 | ||
| Q4 24 | $0.40 | $0.08 | ||
| Q3 24 | $0.41 | $0.36 | ||
| Q2 24 | $-0.09 | $0.00 | ||
| Q1 24 | $-0.10 | $0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $24.3M |
| 总债务越低越好 | $22.7M | $126.7M |
| 股东权益账面价值 | $130.3M | $-29.7M |
| 总资产 | $216.3M | $296.3M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIPRPL
| Q4 25 | $97.5M | $24.3M | ||
| Q3 25 | $94.4M | $32.4M | ||
| Q2 25 | $96.0M | $34.2M | ||
| Q1 25 | $93.2M | $21.6M | ||
| Q4 24 | $101.0M | $29.0M | ||
| Q3 24 | $96.7M | $23.4M | ||
| Q2 24 | $96.8M | $23.4M | ||
| Q1 24 | $107.2M | $34.5M |
总债务PBYIPRPL
| Q4 25 | $22.7M | $126.7M | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | $70.7M | ||
| Q3 24 | $79.3M | $50.8M | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIPRPL
| Q4 25 | $130.3M | $-29.7M | ||
| Q3 25 | $115.3M | $-26.9M | ||
| Q2 25 | $104.7M | $-15.6M | ||
| Q1 25 | $97.1M | $1.3M | ||
| Q4 24 | $92.1M | $20.2M | ||
| Q3 24 | $71.1M | $28.0M | ||
| Q2 24 | $48.5M | $66.4M | ||
| Q1 24 | $51.0M | $65.5M |
总资产PBYIPRPL
| Q4 25 | $216.3M | $296.3M | ||
| Q3 25 | $202.9M | $302.1M | ||
| Q2 25 | $194.9M | $303.8M | ||
| Q1 25 | $196.2M | $293.8M | ||
| Q4 24 | $213.3M | $307.8M | ||
| Q3 24 | $220.7M | $309.3M | ||
| Q2 24 | $205.0M | $362.1M | ||
| Q1 24 | $214.1M | $382.1M |
负债/权益比PBYIPRPL
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | 3.50× | ||
| Q3 24 | 1.12× | 1.82× | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $-7.8M |
| 自由现金流率自由现金流/营收 | 19.1% | -5.5% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $-41.9M |
8季度趋势，按日历期对齐
经营现金流PBYIPRPL
| Q4 25 | $14.4M | $-5.8M | ||
| Q3 25 | $9.7M | $-968.0K | ||
| Q2 25 | $14.1M | $-4.0M | ||
| Q1 25 | $3.6M | $-23.1M | ||
| Q4 24 | $15.6M | $6.8M | ||
| Q3 24 | $11.0M | $1.1M | ||
| Q2 24 | $1.0M | $-8.9M | ||
| Q1 24 | $11.2M | $-16.8M |
自由现金流PBYIPRPL
| Q4 25 | $14.4M | $-7.8M | ||
| Q3 25 | $9.7M | $-1.8M | ||
| Q2 25 | $14.1M | $-7.0M | ||
| Q1 25 | $3.6M | $-25.3M | ||
| Q4 24 | $15.6M | $5.7M | ||
| Q3 24 | $11.0M | $101.0K | ||
| Q2 24 | $1.0M | $-11.0M | ||
| Q1 24 | — | $-19.9M |
自由现金流率PBYIPRPL
| Q4 25 | 19.1% | -5.5% | ||
| Q3 25 | 17.7% | -1.5% | ||
| Q2 25 | 26.8% | -6.6% | ||
| Q1 25 | 7.7% | -24.3% | ||
| Q4 24 | 26.4% | 4.4% | ||
| Q3 24 | 13.7% | 0.1% | ||
| Q2 24 | 2.1% | -9.2% | ||
| Q1 24 | — | -16.5% |
资本支出强度PBYIPRPL
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.1% | 2.2% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.0% | 0.9% | ||
| Q2 24 | 0.0% | 1.7% | ||
| Q1 24 | 0.0% | 2.5% |
现金转化率PBYIPRPL
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | -330.22× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |
